SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig S. Owens who wrote (619)7/28/1999 11:14:00 AM
From: BRAVEHEART  Read Replies (1) of 1494
 
Hi Craig,

Sniffing sources suggest the trials are going well. Not to worry. These trials end in the fall. I don't expect anything early on these matters.

I do believe August is a high probability month for a Pharma collaboration. MERZ get's it's results in August. I believe NTII will collaborate it's two clinicals one way or the other. Hence a WIN WIN situation. On the one hand if MERZ's results are good for a product already used in Europe then NTII win's big. If not NTI would still likely collaborate. Hence still a win for shareholders. This is why I view August positively.

IMO the wait should end as soon as MERZ get's it's data. Either way I believe NTI will have positive outcomes.

Jeffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext